A multispecies system for elucidating proliferative control mechanisms during mammalian skin and musculoskeletal regeneration
Project Number1F32AR083259-01A1
Former Number1F32AR083259-01
Contact PI/Project LeaderALLEN, ROBYN S.
Awardee OrganizationUNIVERSITY OF KENTUCKY
Description
Abstract Text
Abstract
While antifibrotic therapies continue to advance, they fall short when treating large or chronic wounds.
Essential to developing new regenerative strategies is a comprehensive understanding of how cell proliferation
is activated, maintained, and eventually terminated to accurately restore missing tissue. The objective of this
proposal is to determine the cell autonomous mechanisms that permit and control proliferation during complex
tissue regeneration in highly regenerative mammals (spiny mice and rabbits). Spiny mice are unique among
rodents in their ability to regenerate complex skin and musculoskeletal tissues and as such, they represent a
promising model for pinpointing molecular and cellular mechanisms that prevent regeneration in humans.
Fascinatingly, primary dermal fibroblasts from spiny mice and rabbits maintain proliferation in the face of reactive
oxygen species, gamma irradiation, and contact inhibition. These same conditions induce senescence or
quiescence in primary dermal fibroblasts from poorly regenerative mammals (lab mice and rats). This proposal
uses cells from these species to identify how identical signals trigger regeneration in some species and scarring
in others. Further, this proposal utilizes spiny mouse ear pinna regeneration, a highly reproducible and tractable
model of mammalian skin and musculoskeletal regeneration, to further explore pro-regenerative signals in vivo.
In Aim 1, I will examine how stress signals are differentially transduced by cells to determine how fibroblasts
from highly regenerative mammals maintain proliferation in senescence inducing conditions in vitro. I will then
use spiny mouse ear pinna regeneration to determine how this differential stress transduction leads to activation
and maintenance of regenerative response following injury in vivo. In Aim 2, I will identify the mechanisms that
permit primary fibroblasts from spiny mice and rabbits to proliferate at very high cell densities in vitro. I will then
use spiny mouse ear pinna regeneration to determine how these mechanisms regulate proliferation and tissue
size in vivo. I hypothesize that cells from highly regenerative mammals differentially activate signaling pathways
that facilitate cell cycle progression in response to stress and maintain this activity in excess of inhibitory signals
that terminate proliferation in non-regenerative mammals. These studies will generate RNA-seq datasets and
identify candidate genes that will drive discovery in the field and form a basis for my own independent research.
By studying proliferative control during regeneration, we can build a blueprint for the recapitulation of
regeneration in human medicine.
Public Health Relevance Statement
Project Narrative
Skin and musculoskeletal regenerative therapies for large and chronic wounds are limited by an incomplete
understanding of proliferative regulation. This proposal investigates how highly regenerative mammals activate
and maintain cell proliferation in the face of inhibitory conditions to drive regeneration. This work will generate
novel targets for regenerative therapies and high throughput screening tools for evaluating phenotypes
associated with regenerative ability.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
CFDA Code
846
DUNS Number
939017877
UEI
H1HYA8Z1NTM5
Project Start Date
01-August-2024
Project End Date
31-July-2027
Budget Start Date
01-August-2024
Budget End Date
31-July-2025
Project Funding Information for 2024
Total Funding
$79,256
Direct Costs
$79,256
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Arthritis and Musculoskeletal and Skin Diseases
$79,256
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1F32AR083259-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1F32AR083259-01A1
Patents
No Patents information available for 1F32AR083259-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1F32AR083259-01A1
Clinical Studies
No Clinical Studies information available for 1F32AR083259-01A1
News and More
Related News Releases
No news release information available for 1F32AR083259-01A1
History
No Historical information available for 1F32AR083259-01A1
Similar Projects
No Similar Projects information available for 1F32AR083259-01A1